2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
9
Erectile Dysfunction
9
Sexuality
2
Sexual Dysfunction, Physiological
2
Rectal Neoplasms
2
Neoplasms
2
Fatigue
2
Brain Neoplasms
2
Waldenstrom Macroglobulinemia
1
Vascular Malformations
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Solid Tumor
1
Sarcoma
1
Radiation Injuries
1
Pre-Eclampsia
1
Postoperative Complications
1
Penile Neoplasms
1
Pancreatic Neoplasms
1
Neurologic Manifestations
1
Mental Fatigue
1
Lymphoma, Follicular
1
Lymphatic Abnormalities
1
Lymphangioma
1
Infertility
1
Glioma
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Erectile Dysfunction Following Radical Prostatectomy
1
Cholangiocarcinoma
1
Interventions
Sildenafil Citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Erectile Dysfunction Following Radical Prostatectomy
×
Sildenafil Citrate
×
Clear all
NCT06875258
2025-03-13
PEHAB-II
The Netherlands Cancer Institute
Phase 4
Recruiting
198 enrolled